Mariner’s Wave Life Sciences WVE Stock Holding History

Mariner’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$594K	Buy	102,195 +81,304	+389%	+$539K	﹤0.01%	2338
2026 Q1	$151K	Buy	+20,891	New	+$272K	﹤0.01%	3233

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Mariner's WVE Position: Q2 2026 in Review

Mariner increased its Wave Life Sciences (WVE) stake by 389% in Q2 2026, buying an estimated $539K and bringing the position to 102,195 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #2338.

Mariner first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Mariner held 102,195 shares of Wave Life Sciences worth $594K as of Q2 2026.
Mariner bought 81,304 Wave Life Sciences shares in Q2 2026, an estimated $539K.
Wave Life Sciences made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2338 holding.
Mariner first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.